TB Online is no longer maintained. This is an archive of the site. For news on TB please go to: https://globaltbcab.org/

News

Brief news reports on Tuberculosis

Russia's war with Ukraine is devastating for Ukraine's war on TB

TB is a big problem in Ukraine. According to the World Health Organization, the country has the fourth highest incidence of the disease in Europe. And it has one of the highest rates of multidrug-resistant TB anywhere in the world. Experts warn that Russia’s invasion of Ukraine could spark an upsurge in TB and undo a decade of gains in public health.

Read More →

Global Fund calls for renewed urgency in fight to end TB

'If we fail to step up the fight against TB, we must accept that we are effectively abandoning the 2030 goal to end the disease as a public health threat.'

Read More →

CROI 2022 TB round up

Treatment Action Group (TAG) released an overview of TB data reported at the 29th Conference on Retroviruses and Opportunistic Infections (CROI 2022) held virtually on 12-16 February 2022. A summary of major findings and TAG’s take on them are available here.

Read More →

On World TB Day WHO calls for increased investments into TB services and research

Release of updated guidance on management of TB in children and adolescents.

Read More →

TB Quarterly Update: Innovative approaches to finding and treating missing people with TB

The Global Fund to Fight AIDS, Tuberculosis and Malaria released the second edition of the TB Quarterly Update. It is produced on a quarterly basis to share information on the achievements, tools, guidance, best practices and highlights of the TB Strategic Initiative and other TB-related activities.

Read More →

Managing drug interactions in HIV and TB coinfection is complex

Tuberculosis (TB) is a serious health concern, especially when coupled with HIV. Individuals with HIV are more likely to become sick if they are coinfected with TB. Infections among individuals with TB include those in the following categories:

Read More →

Higher dose antibiotic shown safe in TB patients likely more effective in treating deadliest form of TB

A Johns Hopkins Children’s Center-led study in animals suggests that high doses of a widely used antibiotic called rifampin may safely treat and reduce the duration of treatment for the deadliest form of tuberculosis that affects the brain, potentially improving survival rates for patients and decreasing the likelihood of lasting adverse effects of the disease. Additional studies in a small number of people also shed light on how rifampin moves through the body, including into the brain, and how rifampin levels could change during treatments, showing how the research could potentially translate to humans.

Read More →

Study uncovers high rate of subclinical TB among people with HIV

The incidence of subclinical tuberculosis among people with HIV in a South African study was similar to the incidence of clinical TB, suggesting that guidelines recommending symptom-based screening may need to be updated, researchers said.

Read More →

India TB Summit 2022

The India TB Summit 2022 is a virtual public summit that was held on 11-12 March 2022, led and curated by TB experts and survivors under the theme Redesigning TB Care for Equity and Access. The virtual Summit focused on critical issues in TB in India discussing key challenges with regard to the TB epidemic in India from diverse perspectives.

Read More →

Accelerating research and development of new vaccines against TB: a global roadmap

To eliminate TB globally, new effective and affordable vaccines are needed. Initiated and funded by the European and Developing Countries Clinical Trials Partnership (EDCTP), a Global Roadmap for Research and Development of Tuberculosis Vaccines was developed between September 2019 and February 2021. A review, published in The Lancet Infectious Diseases, listed the actions needed to accelerate the development and implementation of new TB vaccines using a participatory process.

Read More →

Page 107 of 895 · Total posts: 10

←First 106 107 108 Last→